India's first nasal Covid vaccine iNCOVACC launched; priced at ₹325/dose
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
Bharat Biotech’s vaccine dubbed as “game changer”; to offer efficient distribution and easy and pain-free administration.
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
Random RT-PCR sampling of passengers arriving at airports has been started; govt committed to taking appropriate steps, said the health minister.
iNCOVACC becomes the world’s first intranasal vaccine to receive both primary series and heterologous booster approval.